Guardant Health Secures FDA Nod for HER2-Mutant NSCLC Diagnostic
PALO ALTO, Calif., June 11, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has approved...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
PALO ALTO, Calif., June 11, 2026 Guardant Health announced that the U.S. Food and Drug Administration (FDA) has approved...
SAN DIEGO, Calif., June 3, 2026 Zepto Life Technology has achieved a significant regulatory milestone after receiving U.S. Food...
HEIDELBERG, Germany, June 2, 2026 Hummingbird Diagnostics announced new research findings that provide important biological evidence supporting its liquid...
CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
STOCKHOLM, Sweden, May 28, 2026 Biovica, a company focused on blood-based cancer monitoring technologies, announced new translational research published...
AUSTIN, Texas — May 27, 2026 Natera, Inc. announced the enrollment of the first patients in the SIGNAL-ER 101...
SINGAPORE, May 28, 2026 Gene Solutions announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
SAN DIEGO, May 22, 2026 ClearNote Health announced that it will present new multi-cohort validation data for its Avantect®...
Boston, Massachusetts, USA, May 21, 2026 Foundation Medicine has announced that the U.S. Food and Drug Administration (FDA) has...
